Patents by Inventor Xianhui Wang

Xianhui Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12287445
    Abstract: A coal rock interface directional detection device based on elastic waves includes: a probe body including an elastic wave receiving device and an elastic wave excitation device spaced set at the top; a protective tube with one end connected to the adapter. The protective tube includes a collection circuit board inside the protective tube, and the collection circuit board is electrically connected to the elastic wave receiving device and the elastic wave excitation device; a sleeve, installed outside the protective tube, with one end connected to the side of the probe body near the adapter and with the other end connected to the side of the protective tube away from the adapter; and a control host, wirelessly connected with the acquisition circuit board. A coal rock interface directional detection method based on elastic waves applied in the coal rock interface directional detection device is also disclosed.
    Type: Grant
    Filed: November 7, 2024
    Date of Patent: April 29, 2025
    Assignee: CHINA UNIVERSITY OF MINING AND TECHNOLOGY, BEIJING
    Inventors: Yifan Zeng, Xianhui Wang, Qiang Wu, Chunsheng Liu, Fei Chen, Jia Zhao, Zhuangjie Cui
  • Publication number: 20250112716
    Abstract: Provided are a configuration method and apparatus for dual-mode converged communication, and a dual-mode converged communication system. The method includes: determining a first operating frequency band of power line communication (PLC) and a second operating frequency band of radio frequency (RF) communication; and configuring a second frequency band number of the second operating frequency band based on a first frequency band number of the first operating frequency band, such that a high-order harmonic frequency of a first operating clock of the PLC and a high-order harmonic frequency of a second operating clock of the RF communication do not overlap with the first operating frequency band or the second operating frequency band. This can reduce an impact of multiplicative noise generated by harmonic superposition and an impact of noise generated by a CPU during operation on performance of a dual-mode converged communication unit, improving transmission efficiency of dual-mode converged communication.
    Type: Application
    Filed: August 14, 2023
    Publication date: April 3, 2025
    Inventors: Zheng Li, Qixin Gao, Kunpeng Xu, Hongguang Dai, Qian Zhang, Xianhui Wang, Weiqi Hao, Zhanxia Wu
  • Publication number: 20230370362
    Abstract: Provided are a networking method, communication method, and communication system for a multi-mode communication device, a device, and a chip. The networking method includes: sending response information about available communication modes between a network access node and a to-be-connected node to the network access node, where the available communication modes are divided into a plurality of sets, and modes in each of the sets are incompatible with each other, and modes in different sets are compatible with each other; and locking an optimal mode, selected from each of the sets based on the response information, as handshake information between the two nodes when a preset negotiation result is met, such that the network access node reports corresponding routing information, and a root node updates networking routing information.
    Type: Application
    Filed: June 5, 2023
    Publication date: November 16, 2023
    Inventors: Yubo Wang, Xianhui Wang, Zheng Li, Kunpeng Xu, Hongguang Dai, Deyong Xiao, Weiqi Hao, Dan Luo, Jin Shao, Yujie Xu, Zhanxia Wu, Wei Liu
  • Publication number: 20230327837
    Abstract: Disclosed are a beacon timeslot allocation method, apparatus, and device. The method includes: determining, based on a type of a beacon frame sent by a node in a system on a highspeed radio frequency (HRF) link, a node sending a standard beacon frame as a first-type node, and a node sending a simplified beacon frame as a second-type node; and in a process of sending a beacon frame on the HRF link by one first-type node, scheduling at least one first-type node and/or second-type node that have/has not been scheduled to perform sending on a highspeed power line carrier (HPLC) link yet to send a beacon frame on the HPLC link, where the scheduled first-type node and/or second-type node do/does not include the one first-type node or a node on a path between the one first-type node and a central coordinator (CCO) in the system.
    Type: Application
    Filed: May 10, 2023
    Publication date: October 12, 2023
    Inventors: Dongyan Zhao, Dan Luo, Zheng Li, Deyong Xiao, Xianhui Wang, Kunpeng Xu, Xiaohui Zhang, Fuyu Pei, Jin Shao, Qian Zhang
  • Publication number: 20220364197
    Abstract: A preparation method of glassless grain-oriented silicon steel includes the following operations. During a decarburization annealing, a thickness of an oxide film on a surface of strip is 1.5-2.5 ?m; an atomic weight ratio of Si element and Fe element in the oxide film satisfies: Si/(Si+Fe)?0.76; during a high-temperature annealing, a cooling stage includes sequentially: cooling with an inner cover when a temperature drops from 1200° C. to 500° C.; wherein a protective gas is a mixed gas containing nitrogen and hydrogen, and a volume percentage of the hydrogen in the mixed gas is >3%; cooling with the inner cover when the temperature drops from 500° C. to 200° C.; wherein the protective gas is nitrogen; and cooling in air by removing the inner cover when the temperature is <200° C.
    Type: Application
    Filed: August 1, 2022
    Publication date: November 17, 2022
    Applicants: SHOUGANG ZHIXIN QIAN'AN ELECTROMAGNETIC MATERIAL CO., LTD., BEIJING SHOUGANG CO., LTD.
    Inventors: Xianhui WANG, Qian GAO, Maolin SUN, Jian GONG, Huiming XIAO, Zhaoyue LIU, Renhao TENG, Songshan ZHAO, Zhiyuan HU, Jiebin QI, Xuechang YOU, Ruifeng LI, Donghe SONG, Aixing WANG
  • Patent number: 11149092
    Abstract: Receptor protein kinases (RPTKs) transmit extracellular signals across the plasma membrane to cytosolic proteins, stimulating formation of complexes that regulate key cellular functions. Over 5 half of the known tyrosine kinases are implicated in human cancers and are therefore highly promising drug targets. A large-scale loss-of-function analysis of tyrosine kinases using RNA interference in the clinically relevant Erb-B2 positive, BT474 breast cancer cell line showed that Bruton's tyrosine kinase (BTK), a cytosolic, non-receptor tyrosine kinase that has been extensively studied for its role in B cell development, is required, in altered form, for BT474 10 breast cancer survival. This alternative form contains an amino-terminal extension that is also present in tumorigenic breast cells at significantly higher levels than in normal breast cells.
    Type: Grant
    Filed: May 1, 2017
    Date of Patent: October 19, 2021
    Assignee: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
    Inventors: Douglas S. Conklin, Cheryl Eifert, Antonis Kourtidis, Xianhui Wang, Leila Kokabee
  • Publication number: 20200289513
    Abstract: Embodiments of the disclosure find application in the field of cancer therapy. Receptor protein kinases (RPTKs) transmit extracellular signals across the plasma membrane to cytosolic proteins, stimulating formation of complexes that regulate key cellular functions. Over half of the known tyrosine kinases are implicated in human cancers and are therefore highly promising drug targets.
    Type: Application
    Filed: May 31, 2020
    Publication date: September 17, 2020
    Inventors: Xianhui Wang, Douglas S. Conklin
  • Patent number: 10705986
    Abstract: Embodiments of this application provide a flash interface controller and an operation command processing method, and relate to the field of data storage. Programmable first type microcode and second type microcode are introduced to a flash interface controller. The first type microcode can be modified through programming to adapt to a procedure of parsing an operation command of a new protocol, and the second type microcode can be modified through programming to adapt to a flash bus operation required by a new flash interface standard. An operation command can be parsed by only fixing logics of physical modules in the flash interface controller and reading first type microcode and second type microcode that are related to the operation command. Therefore, various protocols and flash interface standards can be adapted to, and flexibility is good.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: July 7, 2020
    Assignee: Huawei Technologies Co. Ltd.
    Inventors: Xianhui Wang, Rui Huang, You Li
  • Patent number: 10668068
    Abstract: Embodiments of the invention find application in the field of cancer therapy. Receptor protein kinases (RPTKs) transmit extracellular signals across the plasma membrane to cytosolic proteins, stimulating formation of complexes that regulate key cellular functions. Over half of the known tyrosine kinases are implicated in human cancers and are therefore highly promising drug targets.
    Type: Grant
    Filed: October 7, 2015
    Date of Patent: June 2, 2020
    Assignee: The Research Foundation For The State University Of New York
    Inventors: Xianhui Wang, Douglas S. Conklin
  • Patent number: 10558593
    Abstract: Embodiments of this application provide a flash interface controller and an operation command processing method, and relate to the field of data storage. Programmable first type microcode and second type microcode are introduced to a flash interface controller. The first type microcode can be modified through programming to adapt to a procedure of parsing an operation command of a new protocol, and the second type microcode can be modified through programming to adapt to a flash bus operation required by a new flash interface standard. An operation command can be parsed by only fixing logics of physical modules in the flash interface controller and reading first type microcode and second type microcode that are related to the operation command. Therefore, various protocols and flash interface standards can be adapted to, and flexibility is good.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: February 11, 2020
    Assignee: Huawei Technologies Co. Ltd.
    Inventors: You Li, Rui Huang, Xianhui Wang
  • Publication number: 20190303314
    Abstract: Embodiments of this application provide a flash interface controller and an operation command processing method, and relate to the field of data storage. Programmable first type microcode and second type microcode are introduced to a flash interface controller. The first type microcode can be modified through programming to adapt to a procedure of parsing an operation command of a new protocol, and the second type microcode can be modified through programming to adapt to a flash bus operation required by a new flash interface standard. An operation command can be parsed by only fixing logics of physical modules in the flash interface controller and reading first type microcode and second type microcode that are related to the operation command. Therefore, various protocols and flash interface standards can be adapted to, and flexibility is good.
    Type: Application
    Filed: June 20, 2019
    Publication date: October 3, 2019
    Inventors: You LI, Rui HUANG, Xianhui WANG
  • Patent number: 10421820
    Abstract: Receptor protein kinases (RPTKs) transmit extracellular signals across the plasma membrane to cytosolic proteins, stimulating formation of complexes that regulate key cellular functions. Over half of the known tyrosine kinases are implicated in human cancers and are therefore highly promising drug targets. A large-scale loss-of-function analysis of tyrosine kinases using RNA interference in the clinically relevant Erb-B2 positive, BT474 breast cancer cell line showed that Bruton's tyrosine kinase (BTK), a cytosolic, non-receptor tyrosine kinase that has been extensively studied for its role in B cell development, is required, in altered form, for BT474 breast cancer survival. This alternative form contains an amino-terminal extension that is also present in tumorigenic breast cells at significantly higher levels than in normal breast cells. Thus, embodiments of the invention find application in the field of cancer therapy.
    Type: Grant
    Filed: September 6, 2016
    Date of Patent: September 24, 2019
    Assignee: University Of New York
    Inventors: Douglas S. Conklin, Xianhui Wang, Leila Kokabee
  • Publication number: 20170335011
    Abstract: Receptor protein kinases (RPTKs) transmit extracellular signals across the plasma membrane to cytosolic proteins, stimulating formation of complexes that regulate key cellular functions. Over 5 half of the known tyrosine kinases are implicated in human cancers and are therefore highly promising drug targets. A large-scale loss-of-function analysis of tyrosine kinases using RNA interference in the clinically relevant Erb-B2 positive, BT474 breast cancer cell line showed that Bruton's tyrosine kinase (BTK), a cytosolic, non-receptor tyrosine kinase that has been extensively studied for its role in B cell development, is required, in altered form, for BT474 10 breast cancer survival. This alternative form contains an amino-terminal extension that is also present in tumorigenic breast cells at significantly higher levels than in normal breast cells.
    Type: Application
    Filed: May 1, 2017
    Publication date: November 23, 2017
    Inventors: Douglas Conklin, Cheryl Eifert, Antonis Kourtidis, Xianhui Wang, Leila Kokabee
  • Publication number: 20170189404
    Abstract: Receptor protein kinases (RPTKs) transmit extracellular signals across the plasma membrane to cytosolic proteins, stimulating formation of complexes that regulate key cellular functions. Over half of the known tyrosine kinases are implicated in human cancers and are therefore highly promising drug targets. A large-scale loss-of-function analysis of tyrosine kinases using RNA interference in the clinically relevant Erb-B2 positive, BT474 breast cancer cell line showed that Bruton's tyrosine kinase (BTK), a cytosolic, non-receptor tyrosine kinase that has been extensively studied for its role in B cell development, is required, in altered form, for BT474 breast cancer survival. This alternative form contains an amino-terminal extension that is also present in tumorigenic breast cells at significantly higher levels than in normal breast cells. Thus, embodiments of the invention find application in the field of cancer therapy.
    Type: Application
    Filed: September 6, 2016
    Publication date: July 6, 2017
    Inventors: Douglas S Conklin, Xianhui Wang, Leila Kokabee
  • Patent number: 9637554
    Abstract: Receptor protein kinases (RPTKs) transmit extracellular signals across the plasma membrane to cytosolic proteins, stimulating formation of complexes that regulate key cellular functions. Over half of the known tyrosine kinases are implicated in human cancers and are therefore highly promising drug targets. A large-scale loss-of-function analysis of tyrosine kinases using RNA interference in the clinically relevant Erb-B2 positive, BT474 breast cancer cell line showed that Bruton's tyrosine kinase (BTK), a cytosolic, non-receptor tyrosine kinase that has been extensively studied for its role in B cell development, is required, in altered form, for BT474 breast cancer survival. This alternative form contains an amino-terminal extension that is also present in tumorigenic breast cells at significantly higher levels than in normal breast cells.
    Type: Grant
    Filed: August 4, 2015
    Date of Patent: May 2, 2017
    Assignee: The Research Foundation For The State University Of New York
    Inventors: Douglas S. Conklin, Cheryl Eifert, Antonis Kourtidis, Xianhui Wang, Leila Kokabee
  • Publication number: 20170100401
    Abstract: Embodiments of the invention find application in the field of cancer therapy. Receptor protein kinases (RPTKs) transmit extracellular signals across the plasma membrane to cytosolic proteins, stimulating formation of complexes that regulate key cellular functions. Over half of the known tyrosine kinases are implicated in human cancers and are therefore highly promising drug targets.
    Type: Application
    Filed: October 7, 2015
    Publication date: April 13, 2017
    Inventors: Xianhui Wang, Douglas S. Conklin
  • Publication number: 20160206646
    Abstract: Receptor protein kinases (RPTKs) transmit extracellular signals across the plasma membrane to cytosolic proteins, stimulating formation of complexes that regulate key cellular functions. Over half of the known tyrosine kinases are implicated in human cancers and are therefore highly promising drug targets. A large-scale loss-of-function analysis of tyrosine kinases using RNA interference in the clinically relevant Erb-B2 positive, BT474 breast cancer cell line showed that Bruton's tyrosine kinase (BTK), a cytosolic, non-receptor tyrosine kinase that has been extensively studied for its role in B cell development, is required, in altered form, for BT474 breast cancer survival. This alternative form contains an amino-terminal extension that is also present in tumorigenic breast cells at significantly higher levels than in normal breast cells.
    Type: Application
    Filed: August 20, 2014
    Publication date: July 21, 2016
    Inventors: Douglas S. Conklin, Cheryl Eifert, Antonis Kourtidis, Xianhui Wang, Leila Kokabee
  • Publication number: 20160053024
    Abstract: Receptor protein kinases (RPTKs) transmit extracellular signals across the plasma membrane to cytosolic proteins, stimulating formation of complexes that regulate key cellular functions. Over half of the known tyrosine kinases are implicated in human cancers and are therefore highly promising drug targets. A large-scale loss-of-function analysis of tyrosine kinases using RNA interference in the clinically relevant Erb-B2 positive, BT474 breast cancer cell line showed that Bruton's tyrosine kinase (BTK), a cytosolic, non-receptor tyrosine kinase that has been extensively studied for its role in B cell development, is required, in altered form, for BT474 breast cancer survival. This alternative form contains an amino-terminal extension that is also present in tumorigenic breast cells at significantly higher levels than in normal breast cells.
    Type: Application
    Filed: August 4, 2015
    Publication date: February 25, 2016
    Inventors: Douglas S. Conklin, Cheryl Eifert, Antonis Kourtidis, Xianhui Wang, Leila Kokabee
  • Patent number: 9095592
    Abstract: Receptor protein kinases (RPTKs) transmit extracellular signals across the plasma membrane to cytosolic proteins, stimulating formation of complexes that regulate key cellular functions. Over half of the known tyrosine kinases are implicated in human cancers and are therefore highly promising drug targets. A large-scale loss-of-function analysis of tyrosine kinases using RNA interference in the clinically relevant Erb-B2 positive, BT474 breast cancer cell line showed that Bruton's tyrosine kinase (BTK), a cytosolic, non-receptor tyrosine kinase that has been extensively studied for its role in B cell development, is required, in altered form, for BT474 breast cancer survival. This alternative form contains an amino-terminal extension that is also present in tumorigenic breast cells at significantly higher levels than in normal breast cells.
    Type: Grant
    Filed: August 20, 2013
    Date of Patent: August 4, 2015
    Assignee: THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
    Inventors: Douglas S. Conklin, Cheryl Eifert, Antonis Kourtidis, Xianhui Wang, Leila Kokabee